{"url_path":"/sec/smti/8-k/2026-08-11/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 ****Results","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/714256/0001493152-26-037131-index.html","accession_number":"0001493152-26-037131","cik":"0000714256","ticker":"SMTI","issuer_name":"Sanara MedTech Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/714256/0001493152-26-037131-index.html","primary_entity_key":"0000714256","primary_entity_name":"Sanara MedTech Inc."},"word_count":132,"has_tables":true,"body_markdown":"** **\n\n \n\n \n\n** **\n\n**Item\n2.02****Results\nof Operations and Financial Condition.**\n\n \n\nOn\nAugust 11, 2026, Sanara MedTech Inc. (the “Company”) issued a press release announcing its financial results for the quarter\nended June 30, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and\nis incorporated by reference herein.\n\n \n\nThe\ninformation in this Current Report on Form 8-K, including Exhibit 99.1 furnished hereto, shall not be deemed “filed” for\npurposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the\nliabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended,\nor the Exchange Act, except as expressly set forth in such filing."}